首页> 外国专利> METHOD OF PREDICTING NODAL METASTASIS IN TWO-WAY SYNCHRONOUS INVASIVE CARCINOMA OF NON-SPECIFIC TYPE OF MAMMARY GLANDS

METHOD OF PREDICTING NODAL METASTASIS IN TWO-WAY SYNCHRONOUS INVASIVE CARCINOMA OF NON-SPECIFIC TYPE OF MAMMARY GLANDS

机译:非特定类型乳腺双向同步浸润性癌的结节转移预测方法

摘要

FIELD: medicine.;SUBSTANCE: invention relates to medicine, particularly to oncology and can be used to predict risk of metastasis in lymphatic duplex synchronous invasive carcinoma of nonspecific type mammary glands. Method comprises: histological examination of both mammary glands, in which determination of infiltrative component tissue growth, where number of different types of structures from 1 to 5, among which are additionally alveolar, trabecular, solid structure and discrete group of tumour cells. In presence of structures of any type in infiltrative component tumour said index is estimated as 1 point, in presence of two different types of structures-2 points and so on, then availability or absence in infiltrative component discrete groups of tumour cells, no index is estimated as 1, and if in 2 points, also, intensity of inflammatory infiltration of tumour stroma, without it or presence of mild inflammatory infiltration stroma index is estimated as 1 point at moderate in 2 points, if sharply expressed infiltration stroma index is appraised as 3 points, also tumour stroma hyalinosis is assessed at absence or presence of weakly expressed hyalinosis stroma index is estimated as 1 point, moderately expressed hyalinosis in 2 points, if sharply expressed hyalinosis stroma in 3 points. Further, value of regression equation Y is calculated using a formula, which is used in claim to determine value of probability of developing lymphogenic metastases P. P 50 % shows high, while P 50 % shows a low risk of developing lymphogenic metastases. Sensitivity of method was 100 %, specificity was 83 %.;EFFECT: invention provides improved accuracy and information value of method.;1 cl, 3 tbl, 1 ex
机译:技术领域本发明涉及医学,特别是涉及肿瘤学,并且可以用于预测非特异性类型乳腺的淋巴双发同步浸润癌中转移的风险。方法包括:对两个乳腺进行组织学检查,确定浸润性组织的生长,其中从1到5种不同类型的结构数量,其中还包括肺泡,小梁,实体结构和肿瘤细胞的离散组。在浸润性成分肿瘤中存在任何类型的结构时,所述指数被估计为1分,在两种不同类型的结构性存在中被评估为2分,依此类推,然后在肿瘤细胞的浸润性成分离散组中是否可利用,没有指数是估计为1,如果以2分表示,则不明显或存在轻度炎症浸润基质指数的情况下,肿瘤基质的炎症浸润强度也以2分为中点估计为1分,如果急剧表达的浸润基质指数估计为在没有或存在弱表达的透明质酸基质指数的情况下,也将肿瘤基质透明质酸评估为3分,基质指数在评估中为1分,中等表达的透明质酸评估为2分,如果急剧表达的透明质酸基质则评估为3分。此外,回归公式Y的值是使用公式计算的,该公式在权利要求中用于确定发生淋巴转移的可能性的值P。P> 50%表示较高,而P <50%表示发生淋巴转移的风险较低。方法的灵敏度为100%,特异性为83%。效果:本发明提高了方法的准确性和信息价值。1cl,3 tbl,1 ex

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号